Capricor Therapeutics Inc (CAPR) is a publicly traded Healthcare sector company. As of September 14, 2026, CAPR trades at $8.90 with a market cap of $486.62M and a P/E ratio of -7.30. CAPR moved +0.00% today. Year to date, CAPR is -72.14%; over the trailing twelve months it is +32.23%. Its 52-week range spans $2.96 to $40.37. Analyst consensus is moderatebuy with an average price target of $23.80. Rallies surfaces CAPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks CAPR insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $8.90 |
| Market Cap | $486.62M |
| P/E Ratio | -7.30 |
| EPS | $-1.15 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.37 |
| 52-Week Low | $2.96 |
| Volume | 341.27K |
| Avg Volume | 0 |
| Revenue (TTM) | $22.27M |
| Net Income | $-40.47M |
| Gross Margin | 0.00% |
10 analysts cover CAPR: 0 strong buy, 3 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is moderatebuy. Average price target: $23.80.